Pharmaceutical Manufacturing of Povidone-Iodine Topical Solution

The contract calls for the manufacture of a sterile, FDA-compliant Povidone-Iodine Topical Solution at a concentration of 10% w/v, produced in either unit-dose or bulk containers to meet exacting military medical standards. The product must adhere to stringent regulatory and quality requirements to ensure safety and efficacy for use in deployed military medical settings, with manufacturing processes subject to rigorous validation and documentation to maintain compliance with both FDA regulations and Department of Defense specifications. This is a subcontract opportunity issued by the Defense Logistics Agency under the Department of Defense, identified by NAICS code 325412 for pharmaceutical preparation manufacturing. The solicitation was posted on May 4, 2026, with responses due by May 8, 2026, creating a narrow window for qualified manufacturers to submit proposals. Performance is expected to align with federal military supply chain requirements, though specific place of performance details are not provided. Prospective bidders must demonstrate capability in sterile pharmaceutical production and familiarity with defense medical procurement protocols to be considered eligible.